創薬を指向した天然薬物学研究
スポンサーリンク
概要
- 論文の詳細を見る
The ubiquitin-proteasome system (UPS) plays a major role in selective protein degradation and regulates various cellular events. Approval of bortezomib for the treatment of multiple myeloma validated the proteasome as an anticancer target. In order to find drug candidates targeting the ubiquitin-dependent protein degradation, we paid an attention to inhibitors against three enzymes, ubiquitin-activating enzyme (E1), ubiquitin-conjugating enzyme (E2), and ubiquitin-protein ligase (E3), which are required for polyubiquitination of proteins and prerequisite to proteasome-mediated protein degradation. We succeeded in isolating various compounds with three distinct inhibitory activities against an E1 enzyme reaction, Ubc13 (E2)-Uev1A interaction, and p53-HDM2 (E3) interaction as well as the proteasome inhibitors. We also isolated new alkaloids, notoamides, from a marine-derived Aspergillus sp. Among them, notoamide B and stephacidin A contain a bicyclo[2.2.2]diazaoctane ring in their structures. We proposed this ring is constructed from notoamide E by the intramolecular Diels-Alder (IMDA) reaction. Recently, the isolation of the antipodes of notoamides from the terrestrial Aspergillus has been reported. We propose that each enantiomer is generated by a distinct face-selective IMDA.
論文 | ランダム
- 分子状酸素を利用する光酸化反応の開発
- 人と環境に優しい可視光酸素酸化反応の実用化への展開(平成18年度岐阜薬科大学特別研究費(奨励))
- パーフルオロ界面活性剤をテンプレートとするメソ多孔体の環境負荷低減型合成法の開発(平成15年度岐阜薬科大学特別研究費,一般)
- 変な大腸菌が地球を救う!?
- 光と分子状酸素を用いる有機合成反応